摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

O--glykolsaeure | 90843-76-8

中文名称
——
中文别名
——
英文名称
O--glykolsaeure
英文别名
O-(Phenylacetyl)-glykolsaeure;Phenylacetoxyacetic acid;2-(2-phenylacetyl)oxyacetic acid
O-<Phenylacetyl>-glykolsaeure化学式
CAS
90843-76-8
化学式
C10H10O4
mdl
——
分子量
194.187
InChiKey
WRYJMEQATCHBRJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    14
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    63.6
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Intramolecular Triplet-Triplet Energy Transfer in Short Flexible Bichromophoric Amino Acids, Dipeptides and Carboxylic Acid Diester
    作者:Miroslav Zabadal、Dominik Heger、Petr Klán、Zdeněk Kříž
    DOI:10.1135/cccc20040776
    日期:——

    Efficiencies of the intramolecular triplet-triplet energy transfer (ITET) in various bichromophoric amino acids (glycine, valine, phenylalanine, and sarcosine), dipeptides (glycylglycine, phenylalanylphenylalanine), and a simple diester, with the benzoyl and naphthyl terminal groups serving as donor and acceptor, respectively, have been determined by the steady-state photokinetic measurements. The magnitude of the transfer rate constants (>108 s-1) and the number of bonds separating the chromophores (8 or 11 atoms) suggest a through-space exothermic exchange mechanism in all cases. The influence of interchromophore distance, the character of the connecting chain as well as of side chains, was evaluated. While the most efficient energy transfer was found in a flexible diester and in valine- and sarcosine-based molecules due to the steric effect of the side hydrocarbon groups, the benzyl groups in the phenylalanine and phenylalanylphenylalanine-based bichromophores had a suppressing effect on ITET. Rigidity of the peptide bond in short bichromophoric compounds causes that a large number of favorable geometries preexist already before excitation; thus the intramolecular processes are controlled by ground-state conformational distribution. Replacing this bond by a less rigid ester moiety would allow that certain unfavorable conformations may coil to favorable ones within the excited-state lifetime (a rotation-controlled photochemical model). Some conclusions were supported by a conformational search of the potential energy surface and molecular dynamics simulations.

    各种双色基氨基酸(甘氨酸、缬氨酸、苯丙氨酸和硫氨酸)、二肽(甘氨酰甘氨酸、苯丙氨酰苯丙氨酸)和一个简单的二酯的分子内三重态-三重态能量转移效率(ITET)通过稳态光动力学测量确定。传递速率常数的大小(>10^8 s^-1)和色团之间的键的数量(8或11个原子)表明在所有情况下都存在一种通过空间的放热交换机制。评估了色团间距离、连接链的性质以及侧链的影响。尽管在柔性二酯和以缬氨酸和硫氨酸为基础的分子中发现了最有效的能量转移,这是由于侧链烃基的立体效应,但苯丙氨酸和苯丙氨酰苯丙氨酸双色基色团中的苄基对ITET有抑制作用。短双色基化合物中肽键的刚性导致在激发之前已经存在大量有利的几何构型,因此分子内过程受基态构象分布控制。用较不刚性的酯基团取代这种键将允许在激发态寿命内某些不利的构象转变为有利的构象(一个受旋转控制的光化学模型)。通过对潜在能量表面的构象搜索和分子动力学模拟支持了一些结论。
  • [EN] SUBSTITUTED AMINO PHENYLACETIC ACIDS, DERIVATIVES THEREOF, THEIR PREPARATION AND THEIR USE AS CYCLOOXYGENASE 2 (COX-2) INHIBITORS<br/>[FR] ACIDES AMINO PHENYLACETIQUES SUBSTITUES, DERIVES DE CEUX-CI, PROCEDE POUR LES PREPARER ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE CYCLOOXYGENASE 2 (COX-2)
    申请人:NOVARTIS AG
    公开号:WO2004048314A1
    公开(公告)日:2004-06-10
    Compounds of formula (I) wherein R is hydrogen, lower alkyl, (C3-C8)cycloalkyl, hydroxy, halo, lower alkoxy, trifluoromethoxy, trifluoromethyl or cyano; and A is biaryl, optionally substituted β-naphthyl, bicyclic heterocyclic aryl, (C3-C6)cycloalkylmonocyclic carbocyclic aryl, or (C5 or C6)cycloalkane fused-monocyclic carbocyclic aryl; pharmaceutically acceptable salts thereof, and pharmaceutically acceptable esters thereof; which are useful for the treatment of COX-2 dependent disorders.
    式(I)中R为氢、较低的烷基、(C3-C8)环烷基、羟基、卤素、较低的烷氧基、三氟甲氧基、三氟甲基或氰基;A为联苯、可选择地取代的β-萘基、双环杂环芳基、(C3-C6)环烷基单环碳环芳基,或(C5或C6)环烷烃融合的单环碳环芳基;其药学上可接受的盐,以及其药学上可接受的酯;用于治疗COX-2依赖性疾病。
  • Certain phenylacetic acids and derivatives
    申请人:——
    公开号:US20040132769A1
    公开(公告)日:2004-07-08
    Compounds of formula (I) 1 wherein R is hydrogen, lower alkyl, (C 3 -C 6 )cycloalkyl, hydroxy, halo, lower alkoxy, trifluoromethoxy, trifluoromethyl or cyano; and A is biaryl, optionally substituted &bgr;-naphthyl, bicyclic heterocyclic aryl, (C 3 -C 6 )cycloalkylmonocyclic carbocyclic aryl, or (C 5 or C 6 )cycloalkane fused-monocyclic carbocyclic aryl; pharmaceutically acceptable salts thereof; and pharmaceutically acceptable esters thereof; which are useful for the treatment of COX-2 dependent disorders.
    化学式为(I)1的化合物,其中R为氢、低碳基、(C3-C6)环烷基、羟基、卤素、低烷氧基、三氟甲氧基、三氟甲基或氰基;而A为双芳基、可选取代的β-萘基、双环杂环芳基、(C3-C6)环烷基单环碳环芳基,或(C5或C6)环烷基融合的单环碳环芳基;其药学上可接受的盐和酯,可用于治疗COX-2依赖性疾病。
  • Propylene polymer catalyst donor component
    申请人:Uhrhammer Roger
    公开号:US20080207972A1
    公开(公告)日:2008-08-28
    A solid, hydrocarbon-insoluble, catalyst component useful in polymerizing olefins containing magnesium, titanium, and halogen further contains an internal electron donor comprising a compound containing electron donating substituents with a structure: wherein D 1 and D 2 are selected individually from and R, R 2 , R 3 , R 4 , R 5 , R 6 , and R 7 individually are hydrocarbon or substituted hydrocarbon groups containing 1 to 20 carbon atoms and R 2 , R 3 , R 4 , R 6 , and R 7 may be hydrogen; R 4 may be —NR 2 ; and wherein groups R 1 and R 2 , R 2 and R 3 , R 3 and R 4 , R 3 and R 5 , and groups R 6 and R 7 may be joined to form a cyclic structure.
    一种固体、烃类不溶性催化剂组分,适用于聚合含有镁、钛和卤素的烯烃,进一步包含一种内部电子给体,其包含一种化合物,其含有具有以下结构的电子给体取代基:其中D1和D2分别选自和,R、R2、R3、R4、R5、R6和R7分别是含有1至20个碳原子的烃基或取代烃基,其中R2、R3、R4、R6和R7可以是氢;R4可以是—NR2;以及其中基团R1和R2、R2和R3、R3和R4、R3和R5以及基团R6和R7可以连接形成环状结构。
  • Phenylacetic Acid Derivatives
    申请人:Monovich Lauren G.
    公开号:US20130012585A1
    公开(公告)日:2013-01-10
    Compounds of formula (I) pharmaceutically acceptable salts thereof; and pharmaceutically acceptable esters thereof; which are useful for the treatment of COX-2 dependent disorders.
    化学式为(I)的化合物,其药学上可接受的盐;以及其药学上可接受的酯;这些化合物对于治疗COX-2依赖性疾病是有用的。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐